Effects of DHEA replacement on bone mineral density and body composition in elderly women and men

Clinical Endocrinology

Volumn 53, Issue 5, 2000, Pages 561-568

  Villareal, D T ^a   Holloszy, J O ^a   Kohrt, W M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE;

AGED; AGING; ARTICLE; BODY COMPOSITION; BONE DENSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; AGED; AGED, 80 AND OVER; BODY COMPOSITION; BONE DENSITY; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; ESTROGENS; FEMALE; GLUCOSE TOLERANCE TEST; HORMONE REPLACEMENT THERAPY; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TESTOSTERONE;

EID: 0033740249     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.01131.x     Document Type: Article

References (33)

1. Biotransformation of oral dehydroepinadrosterone in elderly men: Significant increase in circulating estrogens
2. The epidemiology of DHEAS and cardiovascular disease
3. Changes in serum concentration of conjugated and unconjugated steroids in 40-80 year old men
4. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: A six-month trial
5. Hormone replacement therapy in postmenopausal women: Urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density
6. Inhibition of access of bound somatomedin to membrane receptor and immuno-binding sites: A comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum
7. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women
8. Biological variability of serum and urinary N-telopeptides of type I collagen in postmenopausal women
9. Effect of postmenopausal hormone therapy on body weight and waist and hip girths
10. Dehydroepiandrosterone replacement in aging humans
11. Reduction of atherosclerosis by administration of dehydroepiandrosterone
12. DHEA treatment reduces fat accumulation and protects against insulin resistance in male rats
13. DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet
14. Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults
15. HRT preserves increases in bone mineral density and reductions in body fat after a supervised exercise program
16. Additive effects of weight-bearing exercise and estrogen on bone mineral density in older women
17. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: Intracrinology
18. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women
19. Insulin-like growth factors in health and disease
20. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women
21. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age
22. Immunoassay of insulin: Two antibody system
23. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women
24. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men
25. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentration during adulthood
26. Specific binding and effects of dehydroepiandrosterone sulfate (DHEA-S) on skeletal muscle cells: Possible implication for DHEA-S replacement therapy in patients with myotonic dystrophy
27. Lack of effect of dehydroepiandrosterone in obese men
28. Steroid 17-hydroxylation and androgen production by incubated rat adrenal tissue
29. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men - A clinical research center study
30. 2+ precipitation procedure for quantification of high-density lipoprotein cholesterol
31. Dehydroepiandrosterone and diseases of aging
32. Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans
33. Prevention of obesity in A(vy)/a mice by dehydroepiandrosterone